Pharmaceutical Executive-09-01-2017

Features

September 22, 2017

With our latest review indicating declines in shareholder value and shareholder value to sales, those companies that score well in critical profit management metrics such as return on invested capital are best positioned to maintain that crucial edge in performance execution.

Can the pharma industry truly achieve a patient-centric supply chain? How some clinical trial logistics companies are racing ahead in making the patient a key link in the chain.

Pharmaceutical Executive

Despite delay in enforcement of Drug Supply Chain Security Act's new serialization requirement, getting compliant now is key.

Pharmaceutical Executive

Our latest review reveals that those companies scoring well on profit management metrics are best positioned to maintain that crucial edge in performance execution.

Technology and other trends in medicine are driving the need for new strategies and investments in temperature sensitive packaging.

Pharmaceutical Executive
From the Editor

September 06, 2017

A big thank you to you, our readers, for lending your voice to Pharm Exec's editorial mission-giving you the information you need and want. Click ahead for a look at some of the future topics we'll be tackling.

Former critical care nurse Cynthia Schwalm, now executive vice president and president of North American commercial operations for Ipsen, speaks with Pharm Exec about her formula for successful team building internally-and the importance today of stepping outside of the C-suite and into the world of the patient.

Pharmaceutical Executive

Drug pricing, right-to-try, opioids, and OTC improvements still on legislative agenda.

Columns

September 05, 2017

The time is now for pharma to take next steps in tech adoption.

Pharmaceutical Executive

Is report worth a look as potential springboard to addressing future EU ties in healthcare-or just more bluster?

Pharmaceutical Executive
Columns

September 01, 2017

How STEM helps women advance from lab bench to boardroom.

Pharmaceutical Executive
Special Sponsored Section

September 01, 2017

Amid political and economic turmoil in recent years, and resulting shortcomings in healthcare budget, medical infrastructure, and drug access, the Ukraine government is championing the introduction of an unprecedented set of reforms, prompting a significant evolution in the country's healthcare system.

Issue PDF
Pharmaceutical Executive

September 01, 2017

Click the title above to open the Pharmaceutical Executive September 2017 issue in an interactive PDF format.